CoChat

Spatiotemporal pharmacodynamics of meropenem- and tobramycin-treated Pseudomonas aeruginosa biofilms

Haagensen, Janus, Verotta, Davide, Huang, Liusheng, Engel, Joanne, Spormann, Alfred M, Yang, Katherine · 2017 · Journal of Antimicrobial Chemotherapy
Cited by 34

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/jac/dkx288

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Research works printed but not linked: 43

  1. Parsek, 2008, Pattern formation in Pseudomonas aeruginosa biofilms, Curr Opin Microbiol, 11, 560, 10.1016/j.mib.2008.09.015 · DOI
  2. Davies, 2003, Understanding biofilm resistance to antibacterial agents, Nat Rev Drug Discov, 2, 114, 10.1038/nrd1008 · DOI · Paper page
  3. Hoiby, 2015, ESCMID guideline for the diagnosis and treatment of biofilm infections 2014, Clin Microbiol Infect, 21, S1, 10.1016/j.cmi.2014.10.024 · DOI · Paper page
  4. Haagensen, 2006, Differentiation and distribution of colistin- and sodium dodecyl sulfate-tolerant cells in Pseudomonas aeruginosa biofilms, J Bacteriol, 189, 28, 10.1128/JB.00720-06 · DOI · Paper page
  5. Merritt, 2005, Growing and analyzing static biofilms, Curr Protoc Microbiol, 10.1002/9780471729259.mc01b01s00 · DOI · Paper page
  6. Pamp, 2009, Insight into the microbial multicellular lifestyle via flow-cell technology and confocal microscopy, Cytometry A, 75, 90, 10.1002/cyto.a.20685 · DOI · Paper page
  7. Clinical and Laboratory Standards Institute, 2013, Performance Standards for Antimicrobial Susceptibility Testing: Twenty-Third Informational Supplement M100-S23
  8. Moskowitz, 2004, Clinically feasible biofilm susceptibility assay for isolates of Pseudomonas aeruginosa from patients with cystic fibrosis, J Clin Microbiol, 42, 1915, 10.1128/JCM.42.5.1915-1922.2004 · DOI · Paper page
  9. Kuti, 2003, Use of Monte Carlo simulation to design an optimized pharmacodynamic dosing strategy for meropenem, J Clin Pharmacol, 43, 1116, 10.1177/0091270003257225 · DOI · Paper page
  10. Touw, 2007, Population pharmacokinetics of tobramycin administered thrice daily and once daily in children and adults with cystic fibrosis, J Cyst Fibros, 6, 327, 10.1016/j.jcf.2006.12.007 · doi:10.1016/j.jcf.2006.12.007
  11. Haagensen, 2015, New in vitro model to study the effect of human simulated antibiotic concentrations on bacterial biofilms, Antimicrob Agents Chemother, 59, 4074, 10.1128/AAC.05037-14 · DOI
  12. Huang, 2014, Determination of meropenem in bacterial media by LC-MS/MS, J Chromatogr B Analyt Technol Biomed Life Sci, 961, 71, 10.1016/j.jchromb.2014.05.002 · DOI
  13. Heydorn, 2000, Quantification of biofilm structures by the novel computer program COMSTAT, Microbiology, 146, 2395, 10.1099/00221287-146-10-2395 · DOI · Paper page
  14. Csajka, 2006, Pharmacokinetic-pharmacodynamic modelling: history and perspectives, J Pharmacokinet Pharmacodyn, 33, 227, 10.1007/s10928-005-9002-0 · DOI · Paper page
  15. Beal, NONMEM User Guides
  16. Akaike, 1974, A new look at the statistical model identification, IEEE Trans Automat Contr, 19, 716, 10.1109/TAC.1974.1100705 · DOI · Paper page
  17. Hannan, 1987, Rational transfer function approximation, Statist Sci, 2, 135, 10.1214/ss/1177013343 · DOI
  18. Schwarz, 1978, Estimating the dimension of a model, Ann Statist, 6, 461, 10.1214/aos/1176344136 · DOI · Paper page
  19. Purevdorj-Gage, 2005, Phenotypic differentiation and seeding dispersal in non-mucoid and mucoid Pseudomonas aeruginosa biofilms, Microbiology, 151, 1569, 10.1099/mic.0.27536-0 · DOI · Paper page
  20. Chan, 1987, Determination of synergy by two methods with eight antimicrobial combinations against tobramycin-susceptible and tobramycin-resistant strains of Pseudomonas, Diagn Microbiol Infect Dis, 6, 157, 10.1016/0732-8893(87)90101-5 · DOI
  21. Comber, 1977, Synergy between ticarcillin and tobramycin against Pseudomonas aeruginosa and Enterobacteriaceae in vitro and in vivo, Antimicrob Agents Chemother, 11, 956, 10.1128/AAC.11.6.956 · doi:10.1128/aac.11.6.956
  22. Fass, 1982, Comparative in vitro activities of β-lactam-tobramycin combinations against Pseudomonas aeruginosa and multidrug-resistant gram-negative enteric bacilli, Antimicrob Agents Chemother, 21, 1003, 10.1128/AAC.21.6.1003 · doi:10.1128/aac.21.6.1003
  23. Lyon, 1986, In vitro activity of piperacillin, ticarcillin, and mezlocillin alone and in combination with aminoglycosides against Pseudomonas aeruginosa, Antimicrob Agents Chemother, 30, 25, 10.1128/AAC.30.1.25 · doi:10.1128/aac.30.1.25
  24. Klausen, 2003, Involvement of bacterial migration in the development of complex multicellular structures in Pseudomonas aeruginosa biofilms, Mol Microbiol, 50, 61, 10.1046/j.1365-2958.2003.03677.x · DOI · Paper page
  25. Klausen, 2003, Biofilm formation by Pseudomonas aeruginosa wild type, flagella and type IV pili mutants, Mol Microbiol, 48, 1511, 10.1046/j.1365-2958.2003.03525.x · DOI · Paper page
  26. Shrout, 2006, The impact of quorum sensing and swarming motility on Pseudomonas aeruginosa biofilm formation is nutritionally conditional, Mol Microbiol, 62, 1264, 10.1111/j.1365-2958.2006.05421.x · DOI · Paper page
  27. Chua, 2016, Selective labelling and eradication of antibiotic-tolerant bacterial populations in Pseudomonas aeruginosa biofilms, Nat Commun, 7, 10750, 10.1038/ncomms10750 · DOI · Paper page
  28. Webb, 2003, Cell death in Pseudomonas aeruginosa biofilm development, J Bacteriol, 185, 4585, 10.1128/JB.185.15.4585-4592.2003 · DOI · Paper page
  29. Rollet, 2009, Biofilm-detached cells, a transition from a sessile to a planktonic phenotype: a comparative study of adhesion and physiological characteristics in Pseudomonas aeruginosa, FEMS Microbiol Lett, 290, 135, 10.1111/j.1574-6968.2008.01415.x · DOI
  30. Vidal, 2007, Efficacy and safety of aminoglycoside monotherapy: systematic review and meta-analysis of randomized controlled trials, J Antimicrob Chemother, 60, 247, 10.1093/jac/dkm193 · DOI · Paper page
  31. Hilf, 1989, Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients, Am J Med, 87, 540, 10.1016/S0002-9343(89)80611-4 · doi:10.1016/s0002-9343(89)80611-4 · Paper page
  32. Korvick, 1992, Prospective observational study of Klebsiella bacteremia in 230 patients: outcome for antibiotic combinations versus monotherapy, Antimicrob Agents Chemother, 36, 2639, 10.1128/AAC.36.12.2639 · DOI · Paper page
  33. Leibovici, 1997, Monotherapy versus β-lactam-aminoglycoside combination treatment for gram-negative bacteremia: a prospective, observational study, Antimicrob Agents Chemother, 41, 1127, 10.1128/AAC.41.5.1127 · DOI · Paper page
  34. Crabtree, 1999, Analysis of aminoglycosides in the treatment of gram-negative infections in surgical patients, Arch Surg, 134, 1293, 10.1001/archsurg.134.12.1293 · doi:10.1001/archsurg.134.12.1293
  35. Bailey, 2002, Aminoglycosides for intra-abdominal infection: equal to the challenge?, Surg Infect (Larchmt), 3, 315, 10.1089/109629602762539544 · DOI
  36. Paul, 2004, β Lactam monotherapy versus β lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials, BMJ, 328, 668., 10.1136/bmj.38028.520995.63 · DOI · Paper page
  37. Walters, 2003, Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin, Antimicrob Agents Chemother, 47, 317, 10.1128/AAC.47.1.317-323.2003 · DOI · Paper page
  38. Williamson, 2012, Heterogeneity in Pseudomonas aeruginosa biofilms includes expression of ribosome hibernation factors in the antibiotic-tolerant subpopulation and hypoxia-induced stress response in the metabolically active population, J Bacteriol, 194, 2062, 10.1128/JB.00022-12 · DOI · Paper page
  39. Stewart, 1996, Theoretical aspects of antibiotic diffusion into microbial biofilms, Antimicrob Agents Chemother, 40, 2517, 10.1128/AAC.40.11.2517 · DOI · Paper page
  40. Stewart, 1996, Modeling biocide action against biofilms, Biotechnol Bioeng, 49, 445, 10.1002/(SICI)1097-0290(19960220)49:4<445::AID-BIT12>3.0.CO;2-9 · DOI
  41. Kumon, 1994, A sandwich cup method for the penetration assay of antimicrobial agents through Pseudomonas exopolysaccharides, Microbiol Immunol, 38, 615, 10.1111/j.1348-0421.1994.tb01831.x · DOI · Paper page
  42. Shigeta, 1997, Permeation of antimicrobial agents through Pseudomonas aeruginosa biofilms: a simple method, Chemotherapy, 43, 340, 10.1159/000239587 · DOI · Paper page
  43. Nichols, 1988, Inhibition of tobramycin diffusion by binding to alginate, Antimicrob Agents Chemother, 32, 518, 10.1128/AAC.32.4.518 · DOI · Paper page

Cited by

See all 34

Metadata

Authors
Haagensen, J., Verotta, D., Huang, L., Engel, J., Spormann, A. M., & Yang, K.
Affiliations
  • Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, 2800 Kgs Lyngby, Denmark
  • Department of Bioengineering and Therapeutic Sciences, University of California San Francisco School of Pharmacy, San Francisco, CA 94143, USA
  • Department of Clinical Pharmacy, University of California San Francisco School of Pharmacy, San Francisco, CA 94143, USA
  • Departments of Medicine and Microbiology/Immunology, University of California San Francisco, San Francisco, CA 94143, USA
  • Department of Civil and Environmental Engineering, James H. Clark Center, Stanford University, Stanford, CA 94305, USA
Venue
Journal of Antimicrobial Chemotherapy
Published
2017-09-06
Volume
72
Issue
12
Pages
3357-3365
ISSN
  • 0305-7453
  • 1460-2091
Cited by
34
References
6
Language
en
Funders
  • National Institutes of Health (4R01AI738-05)
  • National Institute of Allergy and Infectious Diseases (4R01AI738-05)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Spatiotemporal pharmacodynamics of meropenem- and tobramycin-treated Pseudomonas aeruginosa biofilms. https://app.cochat.ai/papers/10.1093/jac/dkx288
The paper
Haagensen, J., Verotta, D., Huang, L., Engel, J., Spormann, A. M., & Yang, K. (2017). Spatiotemporal pharmacodynamics of meropenem- and tobramycin-treated Pseudomonas aeruginosa biofilms. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkx288

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.